Neuberger Berman High Yield Strategies Fund Inc. (NHS)

NHS Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Operating Revenue	-	-	-	-0	-	-
Other Revenue	22.54	22.8	22.35	17.66	16.32	21.53
Revenue	22.54	22.8	22.35	17.66	16.32	21.53
Revenue Growth (YoY)	-3.52%	2.01%	26.56%	8.20%	-24.20%	-9.37%
Gross Profit	22.54	22.8	22.35	17.66	16.32	21.53
Selling, General & Admin	2.79	2.77	2.55	2.25	2.63	3.55
Operating Expenses	2.79	2.77	2.55	2.25	2.63	3.55
Operating Income	19.74	20.03	19.8	15.42	13.69	17.98
Interest Expense	-4.05	-6.03	-8.46	-2	-2.1	-4.32
Other Non Operating Income (Expenses)	-1.14	-	-	-	-0	0
EBT Excluding Unusual Items	14.55	14	11.34	13.41	11.59	13.67
Gain (Loss) on Sale of Investments	3.94	23.94	-7.62	-46.9	15.21	-10.65
Pretax Income	18.49	37.94	3.72	-33.49	26.8	3.02
Net Income	18.49	37.94	3.72	-33.49	26.8	3.02
Net Income to Common	18.49	37.94	3.72	-33.49	26.8	3.02
Net Income Growth	2.40%	920.57%	-	-	786.80%	-86.58%
Shares Outstanding (Basic)	31	30	26	19	15	20
Shares Outstanding (Diluted)	31	30	26	19	15	20
Shares Change (YoY)	16.46%	14.73%	33.43%	32.52%	-24.96%	-
EPS (Basic)	0.60	1.28	0.14	-1.72	1.83	0.15
EPS (Diluted)	0.60	1.28	0.14	-1.72	1.83	0.15
EPS Growth	-12.07%	789.54%	-	-	1081.74%	-86.58%
Dividend Per Share	1.086	1.086	1.086	1.086	1.086	1.086
Dividend Growth	-	-	-	-	-	15.80%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	87.60%	87.85%	88.60%	87.28%	83.89%	83.50%
Profit Margin	82.06%	166.39%	16.63%	-189.61%	164.18%	14.03%
EBIT	19.74	20.03	19.8	15.42	13.69	17.98
EBIT Margin	87.60%	87.85%	88.60%	87.28%	83.89%	83.50%
Revenue as Reported	-	-	-	17.66	16.32	21.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q